- Release Date: 12/08/13 18:22
- Summary: ALLOT: CRP: Allotment of Shares
- Price Sensitive: No
- Download Document 1.42KB
CRP 12/08/2013 16:22 ALLOT REL: 1622 HRS Chatham Rock Phosphate Limited ALLOT: CRP: Allotment of Shares 12 August 2013 Allotment of Shares Chatham Rock Phosphate Limited (NZX: CRP) advises that it has today undertaken placements at $0.34 per share and at $0.35 per share. 105,714 ordinary shares were issued at an issue price of $0.35 per share to qualified investors. In addition two contractors of the Company (CRP-OCS Consulting Limited and Robin Falconer Associates Ltd) have received 88,236 shares under Contracts for Service at NZD$0.34. These shares represent partial payment for services. Pursuant to those contracts for service the issue price of NZ$0.34 per share reflects the 20 day volume weighted average price of a share on the NZAX market to 1 July 2013. Chris Castle Managing Director Email: [email protected] Class of security: Ordinary shares ISIN: NZWENE0003S0 Number issued: 193,950 ordinary shares Issue price: $0.34 per ordinary share for 88,236 ordinary shares; $0.35 per ordinary share for 105,714 ordinary shares Payment in cash: Yes Fully paid: Yes Percentage of class: 0.138% Purpose of the issue: For working capital purposes and partial consideration of Contracts for Service. Authority for the issue: Board resolutions Date of issue: 12 August 2013 Total number of securities on issue following allotments: 140,269,176 ordinary shares End CA:00239551 For:CRP Type:ALLOT Time:2013-08-12 16:22:32
- Forums
- NZX - By Stock
- CRP
- Ann: ALLOT: CRP: Allotment of Shares
CRP
chatham rock phosphate limited
Add to My Watchlist
0.00%
!
9.3¢

Ann: ALLOT: CRP: Allotment of Shares
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
The Watchlist
PSC
PROSPECT RESOURCES LIMITED
Sam Hosack, MD & CEO
Sam Hosack
MD & CEO
SPONSORED BY The Market Online